Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples